Sierra Space Partners With Redwire To Bring In-Space Biotech Facilities To Customers

Commercial space company Sierra Space has entered into a strategic partnership with Redwire Corporation RDW.

The two companies will collaborate on commercial pharmaceutical and biotech research and developments (R&D) and manufacturing in low-Earth orbit (LEO).

Redwire's flight-proven biotechnology and manufacturing technologies will be integrated into Sierra Space's Large Integrated Flexible Environment (LIFE) habitat platform. This will enable commercial breakthroughs for pharmaceutical drug development and human health research.

Redwire will deliver a suite of space hardware and ground-based equipment, including biotechnology for large molecule crystallization for pharmaceutical structure determination and formulation, thermally conditioned stowage lockers, manufacturing facilities for industrial crystals, and a gradient-temperature furnace.

Hardware development is underway with deliveries expected to begin in the fourth quarter of 2023.

"Redwire is proud to have been selected by Sierra Space to deliver state-of-the-art biopharma and manufacturing facilities for the Sierra LIFE Pathfinder module, leveraging decades of proven microgravity research and development on the International Space Station to provide extraordinary technological and economic benefit to humanity," said Chairman and CEO Peter Cannito.

Price Action: RDW shares are trading higher by 3.13% at $3.30 in premarket Monday.